Skip to content

SCHEDULE 13D/AAccepted Sep 22, 4:20 PM ET

LENZ Therapeutics, Inc. SCHEDULE 13D/A

Versant Venture Capital VI, L.P.

Accepted (ET)

4:20 PM

Sep 22, 2025

Filed

Sep 22, 2025

Documents

1

Size

25.4 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.